
Stephen Willey
Stock Analyst at Stifel Nicolaus
(3.87)
# 1,944
Out of 5,152 analysts
643
Total ratings
41.4%
Success rate
4.5%
Average return
Main Sectors:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CADL Candel Therapeutics | Reiterated: Buy | $22 → $19 | $5.32 | +257.14% | 3 | Nov 13, 2026 | |
| CBIO Crescent Biopharma | Reiterated: Buy | $28 | $12.40 | +125.81% | 21 | Nov 13, 2026 | |
| MGNX MacroGenics | Reiterated: Hold | $4 | $1.97 | +103.05% | 37 | Nov 13, 2026 | |
| ABCL AbCellera Biologics | Rated: Buy | $9 → $14 | $11.02 | +27.04% | 20 | Nov 10, 2026 | |
| BCAX Bicara Therapeutics | Rated: Buy | $45 → $43 | $9.38 | +358.42% | 18 | Nov 10, 2026 | |
| CGEN Compugen | Reiterated: Buy | $4 | $1.96 | +104.08% | 12 | Nov 10, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $6 | $0.611 | +882.00% | 17 | Nov 10, 2026 | |
| JANX Janux Therapeutics | Reiterated: Buy | $34 | $10.31 | +229.78% | 8 | Nov 10, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $46 | $26.04 | +76.65% | 36 | Nov 10, 2026 | |
| CELC Celcuity | Reiterated: Buy | $150 → $135 | $55.60 | +142.81% | 13 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.15 | +769.57% | 28 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $5 | $1.41 | +254.61% | 8 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3.5 | $0.9909 | +253.21% | 17 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $35 | $13.89 | +151.98% | 4 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $40 | $8.56 | +367.29% | 11 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $14.10 | +190.78% | 32 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $5.08 | +77.17% | 13 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $17.83 | +124.34% | 26 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $51 | $68.29 | -25.32% | 57 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $117.80 | +33.28% | 43 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $111 | $77.98 | +42.34% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $119.80 | +66.94% | 30 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $2.73 | +522.71% | 6 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $7.5 | $2.98 | n/a | 17 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $4.34 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $5.10 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $4.76 | n/a | 15 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $0.8072 | n/a | 17 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $5 | $0.4705 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $3.69 | n/a | 6 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $1 | $1.69 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $27 | $0.874 | n/a | 4 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $1.72 | n/a | 11 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $21 | $37.75 | n/a | 5 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $160 | $2.34 | n/a | 1 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $95 → $125 | $149.40 | n/a | 6 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $109 → $114 | $61.43 | n/a | 14 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $48 | $27.39 | n/a | 13 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $16 | $18.40 | n/a | 13 | Apr 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2.5 | $0.00001 | n/a | 3 | Sep 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $26 | $13.99 | n/a | 2 | Apr 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.04 | n/a | 1 | Feb 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $6.30 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $247.77 | n/a | 1 | May 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $101 | - | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $26 | $4.11 | n/a | 3 | Nov 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $7 | $42.53 | n/a | 2 | Apr 8, 2013 |
Candel Therapeutics
Nov 13, 2026
Reiterated: Buy
Price Target: $22 → $19
Current: $5.32
Upside: +257.14%
Crescent Biopharma
Nov 13, 2026
Reiterated: Buy
Price Target: $28
Current: $12.40
Upside: +125.81%
MacroGenics
Nov 13, 2026
Reiterated: Hold
Price Target: $4
Current: $1.97
Upside: +103.05%
AbCellera Biologics
Nov 10, 2026
Rated: Buy
Price Target: $9 → $14
Current: $11.02
Upside: +27.04%
Bicara Therapeutics
Nov 10, 2026
Rated: Buy
Price Target: $45 → $43
Current: $9.38
Upside: +358.42%
Compugen
Nov 10, 2026
Reiterated: Buy
Price Target: $4
Current: $1.96
Upside: +104.08%
Compass Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $6
Current: $0.611
Upside: +882.00%
Janux Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $34
Current: $10.31
Upside: +229.78%
Zymeworks
Nov 10, 2026
Reiterated: Buy
Price Target: $46
Current: $26.04
Upside: +76.65%
Celcuity
Nov 6, 2026
Reiterated: Buy
Price Target: $150 → $135
Current: $55.60
Upside: +142.81%
Nov 6, 2026
Reiterated: Buy
Price Target: $10
Current: $1.15
Upside: +769.57%
Nov 6, 2026
Reiterated: Buy
Price Target: $7 → $5
Current: $1.41
Upside: +254.61%
Nov 5, 2026
Reiterated: Buy
Price Target: $4 → $3.5
Current: $0.9909
Upside: +253.21%
Nov 5, 2026
Reiterated: Buy
Price Target: $36 → $35
Current: $13.89
Upside: +151.98%
Nov 5, 2026
Rated: Buy
Price Target: $40
Current: $8.56
Upside: +367.29%
Nov 4, 2026
Reiterated: Buy
Price Target: $41
Current: $14.10
Upside: +190.78%
Nov 2, 2026
Reiterated: Buy
Price Target: $9
Current: $5.08
Upside: +77.17%
Nov 2, 2026
Reiterated: Buy
Price Target: $40
Current: $17.83
Upside: +124.34%
Oct 30, 2026
Reiterated: Hold
Price Target: $51
Current: $68.29
Upside: -25.32%
Oct 30, 2026
Reiterated: Buy
Price Target: $157
Current: $117.80
Upside: +33.28%
Jul 31, 2026
Reiterated: Buy
Price Target: $111
Current: $77.98
Upside: +42.34%
Jul 17, 2026
Reiterated: Buy
Price Target: $200
Current: $119.80
Upside: +66.94%
Mar 18, 2026
Reiterated: Buy
Price Target: $17
Current: $2.73
Upside: +522.71%
Nov 5, 2025
Reiterated: Buy
Price Target: $9 → $7.5
Current: $2.98
Upside: n/a
Jun 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $4.34
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $25 → $20
Current: $5.10
Upside: n/a
Nov 15, 2024
Reiterated: Buy
Price Target: $4
Current: $4.76
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $7 → $6
Current: $0.8072
Upside: n/a
May 13, 2022
Reiterated: Hold
Price Target: $9 → $5
Current: $0.4705
Upside: n/a
May 13, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $3.69
Upside: n/a
May 11, 2022
Reiterated: Hold
Price Target: $3 → $1
Current: $1.69
Upside: n/a
Mar 12, 2021
Reiterated: Buy
Price Target: $25 → $27
Current: $0.874
Upside: n/a
Mar 11, 2021
Reiterated: Hold
Price Target: $6
Current: $1.72
Upside: n/a
Mar 29, 2019
Reiterated: Buy
Price Target: $18 → $21
Current: $37.75
Upside: n/a
Mar 14, 2019
Reiterated: Hold
Price Target: $160
Current: $2.34
Upside: n/a
Aug 6, 2018
Upgraded: Buy
Price Target: $95 → $125
Current: $149.40
Upside: n/a
Aug 6, 2018
Reiterated: Buy
Price Target: $109 → $114
Current: $61.43
Upside: n/a
Aug 6, 2018
Reiterated: Hold
Price Target: $55 → $48
Current: $27.39
Upside: n/a
Apr 27, 2018
Reiterated: Hold
Price Target: $17 → $16
Current: $18.40
Upside: n/a
Sep 26, 2017
Downgraded: Hold
Price Target: $13 → $2.5
Current: $0.00001
Upside: n/a
Apr 4, 2017
Reiterated: Buy
Price Target: $20 → $26
Current: $13.99
Upside: n/a
Feb 2, 2017
Reiterated: Buy
Price Target: $24
Current: $1.04
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $23
Current: $6.30
Upside: n/a
May 31, 2016
Reiterated: Buy
Price Target: $200
Current: $247.77
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $101
Current: -
Upside: n/a
Nov 7, 2014
Reiterated: Buy
Price Target: $31 → $26
Current: $4.11
Upside: n/a
Apr 8, 2013
Reiterated: Buy
Price Target: $11 → $7
Current: $42.53
Upside: n/a